SEARCH

SEARCH BY CITATION

References

  • Appleyard S. M., Celver J., Pineda V., Kovoor A., Wayman G. A. and Chavkin C. (1999) Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin. J. Biol. Chem. 274, 2380223807.
  • Celver J., Xu M., Jin W., Lowe J. and Chavkin C. (2004) Distinct domains of the mu-opioid receptor control uncoupling and internalization. Mol. Pharmacol. 65, 528537.
  • Celver J., Sharma M. and Kovoor A. (2010) RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors. J. Neurochem. 114, 739749.
  • Cho D., Zheng M., Min C., Ma L., Kurose H., Park J. H. and Kim K. M. (2010) Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D2 receptors. Mol. Endocrinol. 24, 574586.
  • DeWire S. M., Ahn S., Lefkowitz R. J. and Shenoy S. K. (2007) Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69, 483510.
  • Galliera E., Jala V. R., Trent J. O., Bonecchi R., Signorelli P., Lefkowitz R. J., Mantovani A., Locati M. and Haribabu B. (2004) Beta-arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6. J. Biol. Chem. 279, 2559025597.
  • Gimenez L. E., Kook S., Vishnivetskiy S. A., Ahmed M. R., Gurevich E. V. and Gurevich V. V. (2012) Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors. J. Biol. Chem. 287, 90289040.
  • Gurevich V. V. and Gurevich E. V. (2004) The molecular acrobatics of arrestin activation. Trends Pharmacol. Sci. 25, 105111.
  • Gurevich V. V. and Gurevich E. V. (2006) The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol. Ther. 110, 465502.
  • Gurevich V. V., Gurevich E. V. and Cleghorn W. M. (2008) Arrestins as multi-functional signaling adaptors. Handb. Exp. Pharmacol. 186, 1537.
  • Gurevich E. V., Tesmer J. J., Mushegian A. and Gurevich V. V. (2012) G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol. Ther. 133, 4069.
  • Ito K., Haga T., Lameh J. and Sadee W. (1999) Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur. J. Biochem. 260, 112119.
  • Jin W., Brown S., Roche J. P., Hsieh C., Celver J. P., Kovoor A., Chavkin C. and Mackie K. (1999) Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J. Neurosci. 19, 37733780.
  • Kearn C. S., Blake-Palmer K., Daniel E., Mackie K. and Glass M. (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol. 67, 16971704.
  • Key T. A., Foutz T. D., Gurevich V. V., Sklar L. A. and Prossnitz E. R. (2003) N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity. J. Biol. Chem. 278, 40414047.
  • Kovoor A. and Lester H. A. (2002) Gi Irks GIRKs. Neuron 33, 68.
  • Kovoor A., Henry D. J. and Chavkin C. (1995) Agonist-induced desensitization of the mu opioid receptor-coupled potassium channel (GIRK1). J. Biol. Chem. 270, 589595.
  • Kovoor A., Nappey V., Kieffer B. L. and Chavkin C. (1997) Mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in xenopus oocytes. J. Biol. Chem. 272, 2760527611.
  • Lan H., Liu Y., Bell M. I., Gurevich V. V. and Neve K. A. (2009) A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding. Mol. Pharmacol. 75, 113123.
  • Missale C., Nash S. R., Robinson S. W., Jaber M. and Caron M. G. (1998) Dopamine receptors: from structure to function. Physiol. Rev. 78, 189225.
  • Mukherjee S., Gurevich V. V., Preninger A., Hamm H. E., Bader M. F., Fazleabas A. T., Birnbaumer L. and Hunzicker-Dunn M. (2002) Aspartic acid 564 in the third cytoplasmic loop of the luteinizing hormone/choriogonadotropin receptor is crucial for phosphorylation-independent interaction with arrestin2. J. Biol. Chem. 277, 1791617927.
  • Namkung Y. and Sibley D. R. (2004) Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor. J. Biol. Chem. 279, 4953349541.
  • Namkung Y., Dipace C., Javitch J. A. and Sibley D. R. (2009a) G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor. J. Biol. Chem. 284, 1503815051.
  • Namkung Y., Dipace C., Urizar E., Javitch J. A. and Sibley D. R. (2009b) G protein-coupled receptor kinase-2 constitutively regulates D2 dopamine receptor expression and signaling independently of receptor phosphorylation. J. Biol. Chem. 284, 3410334115.
  • Neve K. A., Seamans J. K. and Trantham-Davidson H. (2004) Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24, 165205.
  • Pak Y., O'Dowd B. F., Wang J. B. and George S. R. (1999) Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase. J. Biol. Chem. 274, 2761027616.
  • Qiu Y., Law P. Y. and Loh H. H. (2003) Mu-opioid receptor desensitization: role of receptor phosphorylation, internalization, and representation. J. Biol. Chem. 278, 3673336739.
  • Rascol O. and Fabre N. (2001) Dyskinesia: L-dopa-induced and tardive dyskinesia. Clin. Neuropharmacol. 24, 313323.
  • Rasmussen T. N., Novak I. and Nielsen S. M. (2004) Internalization of the human CRF receptor 1 is independent of classical phosphorylation sites and of beta-arrestin 1 recruitment. Eur. J. Biochem. 271, 43664374.
  • Reiter E., Ahn S., Shukla A. K. and Lefkowitz R. J. (2012) Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu. Rev. Pharmacol. Toxicol. 52, 179197.
  • Remington G. (2003) Understanding antipsychotic ‘atypicality’: a clinical and pharmacological moving target. J. Psychiatry Neurosci. 28, 275284.
  • Seeman P., Schwarz J., Chen J. F. et al. (2006) Psychosis pathways converge via D2high dopamine receptors. Synapse 60, 319346.
  • Shapira M., Keren O., Gafni M. and Sarne Y. (2001) Divers pathways mediate delta-opioid receptor down regulation within the same cell. Brain Res. Mol. Brain Res. 96, 142150.
  • Thibault D., Albert P. R., Pineyro G. and Trudeau L. E. (2011) Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism. J. Biol. Chem. 286, 91749184.
  • Xiang B., Yu G. H., Guo J., Chen L., Hu W., Pei G. and Ma L. (2001) Heterologous activation of protein kinase C stimulates phosphorylation of delta-opioid receptor at serine 344, resulting in beta-arrestin- and clathrin-mediated receptor internalization. J. Biol. Chem. 276, 47094716.